Source: Annual Congress 2007 - Pulmonary circulation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Tcherakian, R. Souza, F. Perros, P. Dorfmuller, M. Humbert (Clamart, France). Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats. Eur Respir J 2007; 30: Suppl. 51, 2102

Member's Comments

No comment yet.

Related content which might interest you: Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1302-1314 Year: 2010 Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001 Hypoxia-induced increase in NO production and eNOS expression by murine pulmonary microvascular endothelial cells Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Is pulmonary hypertension associated with a leakage or an activation of endothelial cells? Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003 Circulating fibrocyte recruitment and differentiation inhibited by treprostinil in pulmonary hypertension murine model Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017 Year: 2018 The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 CCR7 deficiency induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH). Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020